Showing results (51-60 of 196) with videos related to

Sort By:
Pageof 20
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor responseGiorgia Gri, Elena Gallo, Emma Di Carlo, et al.
Frontiers in Cell and Developmental Biology|July 25, 2022
Stromal and Immune Cell Dynamics in Tumor Associated Tertiary Lymphoid Structures and Anti-Tumor Immune ResponsesAlessandra Rossi, Beatrice Belmonte, Silvia Carnevale, et al.
Cancer Research|April 19, 2005
Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejectionCristiana Guiducci, Alain P Vicari, Sabina Sangaletti, et al.
The Journal of Experimental Medicine|November 12, 2003
Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinomaSabina Sangaletti, Antonella Stoppacciaro, Cristiana Guiducci, et al.
Trends in Immunology|May 3, 2017
Rheostatic Functions of Mast Cells in the Control of Innate and Adaptive Immune ResponsesBarbara Frossi, Francesca Mion, Claudio Tripodo, et al.
Iscience|October 3, 2022
Trogocytosis in innate immunity to cancer is an intimate relationship with unexpected outcomesFabrizio Mattei, Sara Andreone, Francesca Spadaro, et al.
Cancer Immunology Research|July 19, 2018
Wnt3a Neutralization Enhances T-cell Responses through Indirect Mechanisms and Restrains Tumor GrowthIlenia Pacella, Ilenia Cammarata, Chiara Focaccetti, et al.
Cancer Immunology, Immunotherapy : CII|February 27, 2004
Angiopoietin decoy secreted at tumor site impairs tumor growth and metastases by inducing local inflammation and altering neoangiogenesisCecilia Melani, Antonella Stoppacciaro, Chiara Foroni, et al.
Cancer Research|February 20, 2004
Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70Chiara Massa, Cristiana Guiducci, Ivano Arioli, et al.
Pageof 20